These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25198664)

  • 1. Targeting Smad2 and Smad3 by miR-136 suppresses metastasis-associated traits of lung adenocarcinoma cells.
    Yang Y; Liu L; Cai J; Wu J; Guan H; Zhu X; Yuan J; Chen S; Li M
    Oncol Res; 2013; 21(6):345-52. PubMed ID: 25198664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smad2/3/4 Pathway Contributes to TGF-β-Induced MiRNA-181b Expression to Promote Gastric Cancer Metastasis by Targeting Timp3.
    Zhou Q; Zheng X; Chen L; Xu B; Yang X; Jiang J; Wu C
    Cell Physiol Biochem; 2016; 39(2):453-66. PubMed ID: 27383203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-206 suppresses TGF-β signalling to limit tumor growth and metastasis in lung adenocarcinoma.
    Watt K; Newsted D; Voorand E; Gooding RJ; Majewski A; Truesdell P; Yao B; Tuschl T; Renwick N; Craig AW
    Cell Signal; 2018 Oct; 50():25-36. PubMed ID: 29935234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-145 and miR-203 represses TGF-β-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells.
    Hu H; Xu Z; Li C; Xu C; Lei Z; Zhang HT; Zhao J
    Lung Cancer; 2016 Jul; 97():87-94. PubMed ID: 27237033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition.
    Yu Y; Luo W; Yang ZJ; Chi JR; Li YR; Ding Y; Ge J; Wang X; Cao XC
    Mol Cancer; 2018 Mar; 17(1):70. PubMed ID: 29510731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth.
    Zhang YX; Yan YF; Liu YM; Li YJ; Zhang HH; Pang M; Hu JX; Zhao W; Xie N; Zhou L; Wang PY; Xie SY
    Cell Death Dis; 2016 Dec; 7(12):e2528. PubMed ID: 28005074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-483-5p promotes invasion and metastasis of lung adenocarcinoma by targeting RhoGDI1 and ALCAM.
    Song Q; Xu Y; Yang C; Chen Z; Jia C; Chen J; Zhang Y; Lai P; Fan X; Zhou X; Lin J; Li M; Ma W; Luo S; Bai X
    Cancer Res; 2014 Jun; 74(11):3031-42. PubMed ID: 24710410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis.
    Tang YN; Ding WQ; Guo XJ; Yuan XW; Wang DM; Song JG
    Nat Commun; 2015 Sep; 6():8230. PubMed ID: 26354229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
    Xiang Y; Zhang Y; Tang Y; Li Q
    Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TWIST1 upregulates miR-214 to promote epithelial-to-mesenchymal transition and metastasis in lung adenocarcinoma.
    Liu C; Luo J; Zhao YT; Wang ZY; Zhou J; Huang S; Huang JN; Long HX; Zhu B
    Int J Mol Med; 2018 Jul; 42(1):461-470. PubMed ID: 29693173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
    Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
    Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcription factor PREP1 induces EMT and metastasis by controlling the TGF-β-SMAD3 pathway in non-small cell lung adenocarcinoma.
    Risolino M; Mandia N; Iavarone F; Dardaei L; Longobardi E; Fernandez S; Talotta F; Bianchi F; Pisati F; Spaggiari L; Harter PN; Mittelbronn M; Schulte D; Incoronato M; Di Fiore PP; Blasi F; Verde P
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):E3775-84. PubMed ID: 25157139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
    Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
    Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-218 suppresses epithelial-to-mesenchymal transition by targeting Robo1 and Ecop in lung adenocarcinoma cells.
    Li YJ; Zhang W; Xia H; Zhang BS; Chen P; Zhao YL; Li J
    Future Oncol; 2017 Dec; 13(28):2571-2582. PubMed ID: 28936884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition by regulating TGFβ1/Smad2 in human non-small cell lung cancer.
    Zhang JX; Zhai JF; Yang XT; Wang J
    Eur Rev Med Pharmacol Sci; 2016 Sep; 20(18):3793-3801. PubMed ID: 27735039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
    Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic
    Ikemori R; Gabasa M; Duch P; Vizoso M; Bragado P; Arshakyan M; Luis IC; Marín A; Morán S; Castro M; Fuster G; Gea-Sorli S; Jauset T; Soucek L; Montuenga LM; Esteller M; Monsó E; Peinado VI; Gascon P; Fillat C; Hilberg F; Reguart N; Alcaraz J
    Cancer Res; 2020 Jan; 80(2):276-290. PubMed ID: 31694906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-β signaling in estrogen receptor positive breast cancer cells.
    Yin K; Yin W; Wang Y; Zhou L; Liu Y; Yang G; Wang J; Lu J
    Oncotarget; 2016 Apr; 7(17):24537-48. PubMed ID: 27014911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-503-3p promotes epithelial-mesenchymal transition in breast cancer by directly targeting SMAD2 and E-cadherin.
    Zhao Z; Fan X; Jiang L; Xu Z; Xue L; Zhan Q; Song Y
    J Genet Genomics; 2017 Feb; 44(2):75-84. PubMed ID: 28161325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.